Literature DB >> 1164596

Comparative bioassay of prostaglandin E2 and its three pulmonary metabolites.

D J Crutchley, P J Piper.   

Abstract

The relative potencies of prostaglandin E2 and its metabolites 15-keto PGE2, 13,14-dihydro-15-keto-PGE2 and 13,14,dihydro-PGE2 were investigated on isolated smooth muscle preparations. These were rat stomach strip, colon and uterus, chick rectum, guinea-pig ileum, trachea and pulmonary artery and rabbit aorta and pulmonary artery. 15-keto PGE2 was equiactive or 1-1.8 times more potent than prostaglandin E2 in relaxing guinea-pig trachea but otherwise the three metabolites were less active than prostaglandin E2 on all preparations.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1164596      PMCID: PMC1666467          DOI: 10.1111/j.1476-5381.1975.tb07581.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  PROSTAGLANDINS AND RELATED FACTORS: XIX. THIN-LAYER CHROMATOGRAPHY OF PROSTAGLANDINS.

Authors:  K GREEN; B SAMUELSSON
Journal:  J Lipid Res       Date:  1964-01       Impact factor: 5.922

2.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

3.  Release of prostaglandins and metabolites from guinea-pig lung: inhibition by catecholamines.

Authors:  A A Mathé; L Levine
Journal:  Prostaglandins       Date:  1973-12

4.  Potent bronchoconstrictor activity of 15-keto prostaglandin F2alpha.

Authors:  W Dawson; R L Lewis; R E McMahon; W J Sweatman
Journal:  Nature       Date:  1974-07-26       Impact factor: 49.962

5.  Proceedings: Increased inactivation of prostaglandin E2 by the rabbit lung during pregnancy.

Authors:  J R Bedwani; P B Marley
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

6.  Inactivation of prostaglandins by the lungs.

Authors:  P J Piper; J R Vane; J H Wyllie
Journal:  Nature       Date:  1970-02-14       Impact factor: 49.962

7.  The biological activities of three metabolites of prostaglandin E 1.

Authors:  E Anggård
Journal:  Acta Physiol Scand       Date:  1966-04
  7 in total
  11 in total

Review 1.  Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.

Authors:  H W Seyberth
Journal:  Klin Wochenschr       Date:  1978-04-15

2.  Bioassay and thin-layer chromatography of prostaglandins and their pulmonary metabolites [proceedings].

Authors:  K J Crutchley; P J Piper
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

3.  Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung.

Authors:  C M Ensor; H Zhang; H H Tai
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  Actions of prostaglandin E2 metabolites on skin microcirculation.

Authors:  W P Kingston; M W Greaves
Journal:  Agents Actions       Date:  1985-03

5.  Introduction to the biosynthesis and metabolism of prostaglandins.

Authors:  P J Piper
Journal:  Postgrad Med J       Date:  1977-11       Impact factor: 2.401

Review 6.  Formation and degradation of prostaglandins in the lung.

Authors:  E Anggard; E Oliw
Journal:  Agents Actions       Date:  1976-07

7.  Release of active substances during anaphylaxis.

Authors:  P J Piper
Journal:  Agents Actions       Date:  1976-07

8.  Lack of release of prostaglandins from isolated perfused lungs during pulmonary hypertension and oedema.

Authors:  E Scott; J Vaage; T Wiberg
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

9.  Pathways of prostaglandin F2alpha metabolism in mammalian kidneys.

Authors:  J R Hoult; P K Moore
Journal:  Br J Pharmacol       Date:  1977-12       Impact factor: 8.739

10.  The catabolism of prostaglandins by rat skin.

Authors:  R Camp; M W Greaves
Journal:  Biochem J       Date:  1980-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.